SLC10A4, a member of the solute carrier family 10, is a transmembrane protein crucial for the cellular uptake of various compounds, including bile acids, steroids, and thyroid hormones. As a transporter located on the cell membrane, SLC10A4 plays a vital role in maintaining cellular homeostasis by regulating the intracellular concentration of its substrates. Its function is essential for multiple physiological processes, such as bile acid recycling, steroid hormone signaling, and thyroid hormone metabolism. Dysfunction of SLC10A4 has been implicated in various pathological conditions, underscoring the significance of its precise regulation in cellular function and health.
Inhibition of SLC10A4 involves a variety of molecular mechanisms aimed at reducing or abolishing its transport activity. One common mechanism of inhibition is the competitive binding of specific inhibitors to the substrate-binding site of SLC10A4, thereby preventing the binding and transport of endogenous substrates. Additionally, inhibitors may act by altering the conformation of SLC10A4 or disrupting its interaction with essential cofactors or regulatory proteins, ultimately impairing its transport function. Furthermore, inhibition of SLC10A4 can occur through the modulation of downstream signaling pathways involved in its regulation, leading to the suppression of transporter expression or activity. Overall, understanding the diverse mechanisms of SLC10A4 inhibition is crucial for elucidating its physiological role.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Inhibits Na+/K+ ATPase, potentially altering cellular ionic gradients that can affect SLC10A4 activity. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $140.00 $680.00 | ||
12β-Hydroxydigitoxin inhibits Na+/K+ ATPase, which can indirectly affect SLC10A4 function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Blocks voltage-gated calcium channels, possibly influencing SLC10A4 by altering intracellular calcium. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Another blocker of voltage-gated calcium channels, may affect SLC10A4 indirectly via calcium homeostasis. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, which could modulate SLC10A4 activity through phosphorylation pathways. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
As a major cell membrane component, it can affect membrane proteins like SLC10A4 by altering membrane properties. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $56.00 | 6 | |
Inhibits Na+/H+ exchangers, potentially affecting ionic balances related to SLC10A4 activity. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selective beta-blocker, may influence SLC10A4 indirectly through modulation of adrenergic signaling. | ||||||
Clonidine | 4205-90-7 | sc-501519 | 100 mg | $235.00 | 1 | |
Alpha-2 adrenergic agonist, can alter neurotransmitter release, potentially modulating SLC10A4 indirectly. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $134.00 $406.00 | 1 | |
Inhibits vesicular monoamine transporters, possibly impacting SLC10A4 by altering neurotransmitter levels. | ||||||